Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients.
Demurtas S, La Verde N, Rota S, Casazza G, Montrasio C, Cheli S, Cona MS, Dalu D, Fasola C, Ferrario S, Filipazzi V, Gambaro A, Tosca N, Clementi E.
Demurtas S, et al. Among authors: montrasio c.
Pharmacogenomics J. 2021 Aug;21(4):491-497. doi: 10.1038/s41397-021-00227-7. Epub 2021 Mar 1.
Pharmacogenomics J. 2021.
PMID: 33649523